|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA01031012
|
hexa-2,4-dienoic acid
|
hexa-2,4-dienoic acid
|
FA 6:2
|
C6H8O2
|
112.052430
|
|
LMFA01031013
|
Lumequic acid
|
(21E)-triacont-21-enoic acid
|
FA 30:1
|
C30H58O2
|
450.443681
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031016
|
mediomycin B
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO15
|
1095.685825
|
|
LMFA01031018
|
penta-2,4-dienoic acid
|
penta-2,4-dienoic acid
|
FA 5:2
|
C5H6O2
|
98.036780
|
|
LMFA01031021
|
trans-2-hexacosenoic acid
|
(2E)-hexacos-2-enoic acid
|
FA 26:1
|
C26H50O2
|
394.381081
|
|
LMFA08020162
|
(E,E)-2,4-Decadienoic isobutylamide
|
(2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide
|
NA 14:2
|
C14H25NO
|
223.193614
|
|
LMFA08020164
|
2,4-Undecadiene-8,10-diynoic acid isobutylamide
|
(2E,4Z)-N-(2-methylpropyl)undeca-2,4-dien-8,10-diynamide
|
NA 15:6
|
C15H19NO
|
229.146664
|
|
LMFA08020165
|
Anacyclin
|
(2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide
|
NA 18:6
|
C18H25NO
|
271.193614
|
|
LMFA08020166
|
asukamycin
|
(2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
|
|
C31H34N2O7
|
546.236603
|
|
LMFA08020167
|
beta-sanshool
|
(2E,6E,8E,10E)-N-(2-methylpropyl)dodeca-2,6,8,10-tetraenamide
|
NA 16:4
|
C16H25NO
|
247.193614
|
|
LMFA08020168
|
BRN 2646116
|
(2E,4E)-N-isobutyl-6-phenyl-hexa-2,4-dienamide
|
NA 16:6
|
C16H21NO
|
243.162314
|
|
LMFA08020172
|
EI-1511-3
|
(2E,4E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienamide
|
|
C27H30N2O7
|
494.205303
|
|
LMFA08020173
|
EI-1511-5
|
(2E,4E,6E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-8-methyldeca-2,4,6-trienamide
|
|
C29H32N2O7
|
520.220953
|
|
LMFA08020174
|
EI-1625-2
|
(2E)-N-[(1S,5R,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-4-methyloct-2-enamide
|
|
C27H32N2O7
|
496.220953
|
|
LMFA08020176
|
FR901463
|
6-[(1E,3E)-5-(5-{[(2Z)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl)-3-methylpenta-1,3-dien-1-yl]-4-C-(chloromethyl)-1,3-dideoxy-alpha-D-erythro-hex-2-ulopyranose
|
|
C27H42NO8Cl
|
543.259897
|
|
LMFA08020177
|
FR901464
|
(2S,3Z)-5-{[(2R,3R,5S,6S)-6-{(2E,4E)-5-[(3R,4R,5R,7S)-4,7-dihydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]-3-methylpenta-2,4-dien-1-yl}-2,5-dimethyltetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate
|
NA 27:7;O7
|
C27H41NO8
|
507.283219
|
|
LMFA08020178
|
FR901465
|
(2S,3Z)-5-{[(2R,3R,5S,6S)-2,5-dimethyl-6-{(2E,4E)-3-methyl-5-[(3R,4R,5R,7S,8R)-4,7,8-trihydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]penta-2,4-dien-1-yl}tetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate
|
NA 27:7;O8
|
C27H41NO9
|
523.278134
|
|
LMFA08020179
|
gamma-sanshool
|
N-(2-methylpropyl)tetradeca-2E,4E,8Z,10E,12E-pentaenamide
|
NA 18:5
|
C18H27NO
|
273.209264
|
|
LMFA08020180
|
Herculin
|
(2E,8E)-N-(2-methylpropyl)dodeca-2,8-dienamide
|
NA 16:2
|
C16H29NO
|
251.224914
|
|
LMFA08020181
|
Hydroxy-epsilon-sanshool
|
(2E,6Z,8E,10Z)-N-(2-hydroxy-2-methylpropyl)dodeca-2,6,8,10-tetraenamide
|
NA 16:4;O
|
C16H25NO2
|
263.188529
|
|
LMFA08020185
|
manumycin
|
(2E,4E,6R)-N-[(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-cyclopenten-1-yl)amino]-7-oxo-hepta-1,3,5-trienyl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyl-deca-2,4-dienamide
|
|
C31H38N2O7
|
550.267903
|
|
LMFA08020186
|
N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide
|
(2E,4E,8E,10E,12E)-N-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide
|
NA 18:5;O
|
C18H27NO2
|
289.204179
|
|
LMFA08020190
|
N,N-diethyl-3-hydroxybut-2-enamide
|
N,N-diethyl-3-hydroxybut-2-enamide
|
NA 8:1;O
|
C8H15NO2
|
157.110279
|
|
LMFA08020191
|
N-Cyclopropyl-trans-2-cis-6-nonadienamide
|
(2E,6Z)-N-cyclopropylnona-2,6-dienamide
|
NA 12:3
|
C12H19NO
|
193.146664
|
|
LMFA08020192
|
Neopellitorine A
|
(2E,4E)-N-(2-methylpropyl)undeca-2,4-dien-7,9-diynamide
|
NA 15:6
|
C15H19NO
|
229.146664
|
|
LMFA08020193
|
N-Ethyl trans-2-cis-6-nonadienamide
|
(2E,6Z)-N-ethylnona-2,6-dienamide
|
NA 11:2
|
C11H19NO
|
181.146664
|
|
LMFA08020194
|
N-formylmaleamic acid
|
(2Z)-4-formamido-4-oxobut-2-enoic acid
|
NA 5:3;O3
|
C5H5NO4
|
143.021859
|
|
LMFA08020195
|
N-Isobutyl-2,4,8,10,12-tetradecapentaenamide
|
(2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide
|
NA 18:5
|
C18H27NO
|
273.209264
|
|
LMFA08020199
|
phenyl [1-(N-succinylamino)pentyl]phosphonate
|
4-({(1R)-1-[(R)-hydroxy(phenoxy)phosphoryl]pentyl}amino)-4-oxobutanoic acid
|
|
C15H22NO6P
|
343.118475
|
|
LMFA08020200
|
Pipericine
|
(2E,4E)-N-(2-methylpropyl)octadeca-2,4-dienamide
|
NA 22:2
|
C22H41NO
|
335.318814
|
|
LMFA08020204
|
TMC-1A
|
(2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide
|
|
C28H36N2O7
|
512.252253
|
|
LMFA08020205
|
TMC-1C
|
(2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide
|
|
C30H38N2O7
|
538.267903
|
|
LMFA08020206
|
TMC-1D
|
(2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide
|
|
C30H40N2O7
|
540.283553
|
|
LMFA07070010
|
(11Z)-eicoseneoylcarnitine
|
3-[(11Z)-icos-11-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 20:1
|
C27H51NO4
|
453.381810
|
|
LMFA07070011
|
(11Z,14Z)-eicosadienoylcarnitine
|
3-[(11Z,14Z)-icosa-11,14-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 20:2
|
C27H49NO4
|
451.366160
|
|
LMFA07070012
|
(13Z,16Z)-docosadienoylcarnitine
|
3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 22:2
|
C29H53NO4
|
479.397460
|
|
LMFA07070013
|
(2E)-hexenedioylcarnitine
|
3-{[(2E)-5-carboxypent-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 6:2;O2
|
C13H21NO6
|
287.136889
|
|
LMFA07070014
|
(2E)-octenoylcarnitine
|
3-[(2E)-oct-2-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 8:1
|
C15H27NO4
|
285.194009
|
|
LMFA07070015
|
(2E,4Z)-decadienoylcarnitine
|
3-[(2E,4Z)-deca-2,4-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:2
|
C17H29NO4
|
311.209659
|
|
LMFA07070016
|
(2E,5Z,7E)-decatrienoylcarnitine
|
3-[(2E,5Z,7E)-deca-2,5,7-trienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:3
|
C17H27NO4
|
309.194009
|
|
LMFA07070017
|
(4Z)-decenoylcarnitine
|
3-[(4Z)-dec-4-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4
|
313.225309
|
|
LMFA07070018
|
(5Z)-13-carboxytridec-5-enoylcarnitine
|
3-{[(5Z)-13-carboxytridec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:2;O2
|
C21H37NO6
|
399.262089
|
|
LMFA07070019
|
(5Z,8Z)-3-hydroxytetradecadienoylcarnitine
|
3-{[(5Z,8Z)-3-hydroxytetradeca-5,8-dienoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:2;O
|
C21H37NO5
|
383.267174
|
|
LMFA07070020
|
(5Z,8Z)-tetradecadienoylcarnitine
|
3-[(5Z,8Z)-tetradeca-5,8-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070021
|
(7Z,10Z)-hexadecadienoylcarnitine
|
3-[(7Z,10Z)-hexadeca-7,10-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070022
|
(7Z,10Z,13Z,16Z)-docosatetraenoylcarnitine
|
3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 22:4
|
C29H49NO4
|
475.366160
|
|
LMFA07070023
|
(7Z,10Z,13Z,16Z,19Z)-docosapentaenoylcarnitine
|
3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 22:5
|
C29H47NO4
|
473.350510
|
|
LMFA07070024
|
(9Z)-3-hydroxydodecenoylcarnitine
|
3-{[(9Z)-3-hydroxydodec-9-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070025
|
(9Z)-3-hydroxyoctadecenoylcarnitine
|
3-{[(9Z)-3-hydroxyoctadec-9-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 18:1;O
|
C25H47NO5
|
441.345425
|